RecruitingPhase 3NCT07169643

Darbepoetin in Patients Candidates for Liver Transplant. (EPO-LT Trial)

Darbepoetin in Patients Candidates for Liver Transplant: Randomized Clinical Trial Protocol. (EPO-LT Trial)

Sponsor

Fundacion Clinic per a la Recerca Biomédica

Enrollment

140 participants

Start Date

Nov 25, 2025

Study Type

INTERVENTIONAL

Conditions

Liver Transplant; Complications

Summary

This is a national multicenter, randomized clinical trial to evaluate the the efficacy and safety of DP administration in patients on the liver transplant waiting list to reduce intraoperative red blood cell concentrate transfusion.

Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Darbepoetin (DP) for people with liver transplant; complications. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDarbepoetin (DP)

Darbepoetin (DP) 1.5 mcg/kg subcutaneously, monthly (The patients will receive medication monthly until the liver transplant is performed or if it has not yet been transplanted, a maximum of 3 doses)

Locations(1)

Hospital Clinic de Barcelona

Barcelona, Catalonia, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07169643

Related Trials

Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation

NCT069050541 location

Magnetic Resonance Cholangiopancreatography in Living Liver Donors and Its Relationship With Post Operative Recipient Biliary Complications

NCT077155001 location

Perioperative Hemostasis Management in Liver Transplantation

NCT0625740716 locations

Verification of Risk Factors of Thrombohemorrhagic Complications in Recipients After Related Liver Transplantation

NCT061695921 location

Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)

NCT069587962 locations